2.4 Considerations for interpreting the data The AURA Surveillance System continues to develop the breadth and capacity of AMR and AU surveillance data for the hospital and community sectors. Although this report offers access to a range of data not previously available, a number of considerations should be noted: Limited data is currently available for AMR in the community, including residential aged care facilities. Data on AMR in public hospitals is from the OrgTRx passive surveillance system. For 2014, this includes data from public hospitals and health services from Queensland only. The OrgTRx system has recently expanded to include a large private sector laboratory service in Queensland and data captured by ACT Pathology (in the Australian Capital Territory). Further expansion of passive AMR surveillance through OrgTRx is under way, with discussions on including services in New South Wales, Tasmania, the Northern Territory and Victoria, and some other private sector laboratories. Future reports will therefore represent a greater breadth of data in this area. AMR data from private hospitals, residential aged care facilities and the community is from SNP. For 2014, this includes data from SNP services in Queensland and northern New South Wales only. The AURA Surveillance System has identified Salmonella and Shigella as priority organisms for surveillance. Data for these organisms is currently being captured through passive surveillance. The expansion of OrgTRx will increase the capacity to review and report on Salmonella and Shigella. At this stage of development of the system, while some elements of surveillance can be analysed for trends over time, there is insufficient longitudinal data to undertake time-series analyses across the board.
2.4 Considerations for interpreting the data The AURA Surveillance System continues to develop the breadth and capacity of AMR and AU surveillance data for the hospital and community sectors. Although this report offers access to a range of data not previously available, a number of considerations should be noted: Limited data is currently available for AMR in the community, including residential aged care facilities. Data on AMR in public hospitals is from the OrgTRx passive surveillance system. For 2014, this includes data from public hospitals and health services from Queensland only. The OrgTRx system has recently expanded to include a large private sector laboratory service in Queensland and data captured by ACT Pathology (in the Australian Capital Territory). Further expansion of passive AMR surveillance through OrgTRx is under way, with discussions on including services in New South Wales, Tasmania, the Northern Territory and Victoria, and some other private sector laboratories. Future reports will therefore represent a greater breadth of data in this area. AMR data from private hospitals, residential aged care facilities and the community is from SNP. For 2014, this includes data from SNP services in Queensland and northern New South Wales only. The AURA Surveillance System has identified Salmonella and Shigella as priority organisms for surveillance. Data for these organisms is currently being captured through passive surveillance. The expansion of OrgTRx will increase the capacity to review and report on Salmonella and Shigella. At this stage of development of the system, while some elements of surveillance can be analysed for trends over time, there is insufficient longitudinal data to undertake time-series analyses across the board.
AURA-2016-First-Australian-Report-on-Antimicrobial-use-and-resistance-in-human-health.docx